The chemokine CXCL10 is expressed in the central nervous system (CNS) during neuroinflammatory conditions. Neurons express CXCR3, the receptor for CXCL10, and neuronal function has been shown to be altered by acute exposure to CXCL10. Little is known about the effects of chronic exposure to CXCL10 on neuronal function. Results from our studies show that chronic exposure of cultured rat hippocampal neurons to CXCL10 results in altered levels of protein for GABA and glutamate receptors and altered synaptic network activity. These effects of CXCL10 may contribute to altered CNS function that occurs in some chronic neuroinflammatory conditions.
Introduction
Emerging research indicates that chemokines and their receptors are part of a signaling system within the CNS that is utilized for communication between cells of the CNS as well as between immune cells and cells of the CNS (Adler et al., 2005) . Although a number of chemokines are expressed in the CNS, there is growing interest in the role of CXCL10, primarily driven by the higher expression of this chemokine in certain neuroinflammatory conditions and correlations between a high level of expression of CXCL10 and altered CNS function. For example, CXCL10 levels in the CSF are elevated in HIV infection, with higher levels in HIV-infected individuals with neurologic disorders than in HIV-infected individuals without neurological deficits (Cinque et al., 2005; Kolb et al., 1999) . Moreover, a significant positive correlation between scores on standardized mental tests and CXCL10 concentrations in the CSF was observed in Alzheimer's patients with mild cognitive dysfunction (Galimberti et al., 2006) . CNS cells, including neurons and glia, have been shown to express CXCR3, the receptor for CXCL10 (Bajetto et al., 2002; Biber et al., 2002; Flynn et al., 2003; Tran et al., 2007; Xia et al., 2000) , and to produce CXCL10 under normal conditions or during pathological states, when chemokine production can be significantly elevated (Carter et al., 2007; Klein et al., 2005; Oh et al., 1999; Omari et al., 2005; Van Heteren et al., 2008; Wang et al., 1998) . The expression of CXCR3 by CNS neurons suggests a role for neurons as a target for CXCL10 in the CNS. However, little is known about the neuronal effects of CXCL10. Recent studies of synaptic function in hippocampal slices from adult mice showed that acute exposure to CXCL10 reduced hippocampal long-term potentiation (LTP) at the Schaffer collateral to CA1 pyramidal neuron synapse (Vlkolinsky et al., 2004) . LTP is a form of synaptic plasticity that is considered to be a cellular mechanism of learning and memory (Miyamoto, 2006) . There was no effect of CXCL10 on basal synaptic responses (Vlkolinsky et al., 2004) . Another study showed that acute exposure to CXCL10 altered spontaneous synaptic network activity, spike firing and intracellular Ca 2+ levels associated with the synaptic network activity in the cultured hippocampal neurons (Nelson and Gruol, 2004) . Taken together, these two studies showing that acute exposure to CXCL10 can alter neuronal activity support a potential role for CXCL10 signaling in normal CNS physiology or during neuroinflammatory conditions associated with CNS disease or injury. During neuroinflammation, CNS levels of CXCL10 can be upregulated for a prolonged period. Our recent studies showed that prolonged exposure to CXCL10 produced alterations in the level of protein for signal transduction molecules that regulate neuronal function (e.g., ERK1/2) and transcription factors that regulate gene expression in rat hippocampal cultures (e.g., CREB) (Bajova et al., 2008) . These results raise the possibility that the levels of other neuronal proteins that are important for neuronal function are also altered by prolonged CXCL10 exposure. To address this possibility, in the current study we examined the effect of chronic exposure to CXCL10 on the relative level of synaptic proteins and synaptic network activity in rat hippocampal cultures. 
